Anti-CD5L antibody(DMC441), IgG1 Chimeric mAb-抗體-抗體-生物在線
締碼生物科技(武漢)有限公司
Anti-CD5L antibody(DMC441), IgG1 Chimeric mAb

Anti-CD5L antibody(DMC441), IgG1 Chimeric mAb

商家詢價

產品名稱: Anti-CD5L antibody(DMC441), IgG1 Chimeric mAb

英文名稱: Anti-CD5L antibody(DMC441), IgG1 Chimeric mAb

產品編號: DMC100441

產品價格: null

產品產地: China

品牌商標: DIMA Biotech

更新時間: null

使用范圍:

締碼生物科技(武漢)有限公司
  • 聯系人 :
  • 地址 : 武漢市洪山區東湖高新區高新大道666號光谷生物城B7
  • 郵編 : 430070
  • 所在區域 : 湖北
  • 電話 : 151****5168 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : cygao@dimabio.com

Secreted protein that acts as a key regulator of lipid synthesis: mainly expressed by macrophages in lymphoid and inflamed tissues and regulates mechanisms in inflammatory responses, such as infection or atherosclerosis. Able to inhibit lipid droplet size in adipocytes. Following incorporation into mature adipocytes via CD36-mediated endocytosis, associates with cytosolic FASN, inhibiting fatty acid synthase activity and leading to lipolysis, the degradation of triacylglycerols into glycerol and free fatty acids (FFA). CD5L-induced lipolysis occurs with progression of obesity: participates in obesity-associated inflammation following recruitment of inflammatory macrophages into adipose tissues, a cause of insulin resistance and obesity-related metabolic disease. Regulation of intracellular lipids mediated by CD5L has a direct effect on transcription regulation mediated by nuclear receptors ROR-gamma (RORC). Acts as a key regulator of metabolic switch in T-helper Th17 cells. Regulates the expression of pro-inflammatory genes in Th17 cells by altering the lipid content and limiting synthesis of cholesterol ligand of RORC, the master transcription factor of Th17-cell differentiation. CD5L is mainly present in non-pathogenic Th17 cells, where it decreases the content of polyunsaturated fatty acyls (PUFA), affecting two metabolic proteins MSMO1 and CYP51A1, which synthesize ligands of RORC, limiting RORC activity and expression of pro-inflammatory genes. Participates in obesity-associated autoimmunity via its association with IgM, interfering with the binding of IgM to Fcalpha/mu receptor and enhancing the development of long-lived plasma cells that produce high-affinity IgG autoantibodies (By similarity). Also acts as an inhibitor of apoptosis in macrophages: promotes macrophage survival from the apoptotic effects of oxidized lipids in case of atherosclerosis (PubMed:24295828). Involved in early response to microbial infection against various pathogens by acting as a pattern recognition receptor and by promoting autophagy (PubMed:16030018, PubMed:24223991, PubMed:24583716, PubMed:25713983).